Curated News: Medical Meetings

Filters close
Newswise: New Study Identifies Sexual Activity as Asthma Trigger
4-Nov-2022 8:00 AM EDT
New Study Identifies Sexual Activity as Asthma Trigger
American College of Allergy, Asthma and Immunology (ACAAI)

A new study being presented at this year’s ACAAI Annual Scientific Meeting in Louisville, KY, shows that sex can be an undiagnosed trigger for asthma exacerbations.

Newswise: Study Shows 86.4% of Infants with Anaphylaxis Appropriately Received Epinephrine
4-Nov-2022 8:00 AM EDT
Study Shows 86.4% of Infants with Anaphylaxis Appropriately Received Epinephrine
American College of Allergy, Asthma and Immunology (ACAAI)

A new study being presented at this year’s ACAAI Annual Scientific Meeting shows that, in infants aged 0-24 months who presented to the emergency department for anaphylaxis, few required hospitalization and most were able to go home after a few hours of observation.

Newswise: Only 52% of Adults with Severe Food Allergy Have Been Prescribed an Epinephrine Auto Injector
4-Nov-2022 8:00 AM EDT
Only 52% of Adults with Severe Food Allergy Have Been Prescribed an Epinephrine Auto Injector
American College of Allergy, Asthma and Immunology (ACAAI)

A new study being presented at this year’s ACAAI Annual Scientific Meeting shows that only half of food allergic adult patients have immediate access to epinephrine, and 36% of adults believe epinephrine auto injectors can cause negative or life-threatening effects.

Newswise: Solo al 52 % de los adultos con alergia grave a los alimentos se le ha prescrito un autoinyector de epinefrina
4-Nov-2022 8:00 AM EDT
Solo al 52 % de los adultos con alergia grave a los alimentos se le ha prescrito un autoinyector de epinefrina
American College of Allergy, Asthma and Immunology (ACAAI)

Un nuevo estudio que se presenta en la Reunión científica anual del ACAAI muestra que solo la mitad de los pacientes adultos alérgicos a los alimentos tienen acceso inmediato a la epinefrina y que el 36 % de los adultos creen que los autoinyectores de epinefrina pueden causar efectos negativos o potencialmente mortales.

Newswise: Un nuevo estudio identifica la actividad sexual como desencadenante del asma
4-Nov-2022 8:00 AM EDT
Un nuevo estudio identifica la actividad sexual como desencadenante del asma
American College of Allergy, Asthma and Immunology (ACAAI)

Un nuevo estudio que se presenta en la Reunión Científica Anual del ACAAI muestra que el sexo puede ser un desencadenante no diagnosticado de las exacerbaciones del asma.

Newswise: Lowest Pollen Counts Occur Between 4:00 a.m. and Noon
4-Nov-2022 8:00 AM EDT
Lowest Pollen Counts Occur Between 4:00 a.m. and Noon
American College of Allergy, Asthma and Immunology (ACAAI)

A new study being presented at this year’s ACAAI Annual Scientific Meeting suggests that early morning hours are better than later in the afternoon for dodging pollen.

Newswise: Even in States with Strong Stock Albuterol Laws, School Administrators Fear Liability
4-Nov-2022 8:00 AM EDT
Even in States with Strong Stock Albuterol Laws, School Administrators Fear Liability
American College of Allergy, Asthma and Immunology (ACAAI)

A new study being presented at this year’s ACAAI Annual Scientific Meeting shows that even in states with strong stock inhaler/albuterol laws, school administrators and prescribing clinicians fear liability in prescribing and administering the stock inhalers.

Newswise: Los teléfonos inteligentes son depósitos de alérgenos
4-Nov-2022 8:00 AM EDT
Los teléfonos inteligentes son depósitos de alérgenos
American College of Allergy, Asthma and Immunology (ACAAI)

Un nuevo estudio que se presenta en la Reunión Científica Anual del ACAAI de este año muestra niveles elevados de alérgenos de gatos y perros, así como de glucanos β-D y endotoxinas en modelos telefónicos simulados.

Newswise: 86.4 % de los bebés con anafilaxia recibieron epinefrina de manera adecuada
4-Nov-2022 8:00 AM EDT
86.4 % de los bebés con anafilaxia recibieron epinefrina de manera adecuada
American College of Allergy, Asthma and Immunology (ACAAI)

Un nuevo estudio que se presentó en la Reunión Científica Anual del ACAAI de este año muestra que de los bebés de 0 a 24 meses que acudieron al servicio de urgencias por anafilaxia, pocos requirieron hospitalización y la mayoría pudo irse a casa después de unas horas de observación.

Newswise: Los recuentos de polen más bajos se producen entre las 4:00 a. m. y el mediodía
4-Nov-2022 8:00 AM EDT
Los recuentos de polen más bajos se producen entre las 4:00 a. m. y el mediodía
American College of Allergy, Asthma and Immunology (ACAAI)

Un nuevo estudio que se presenta en la Reunión Científica Anual del ACAAI de este año sugiere que las primeras horas de la mañana son mejores que las últimas de la tarde para evitar el polen.

Newswise: Smartphones are Reservoirs of Allergens According to New Research
4-Nov-2022 8:00 AM EDT
Smartphones are Reservoirs of Allergens According to New Research
American College of Allergy, Asthma and Immunology (ACAAI)

A new study being presented at this year’s ACAAI Annual Scientific Meeting in Louisville, KY, showed elevated levels of cat and dog allergens, as well as β-D glucans (BDG) and endotoxin on simulated phone models.

Newswise: CRISPR Treatment Slows Swelling in Hereditary Angioedema Patients
4-Nov-2022 8:00 AM EDT
CRISPR Treatment Slows Swelling in Hereditary Angioedema Patients
American College of Allergy, Asthma and Immunology (ACAAI)

A new study being presented at this year’s ACAAI Annual Scientific Meeting shows a treatment using the CRISPR genome editing technology succeeded in alleviating swelling and reducing the frequency of attacks.

Newswise: El tratamiento CRISPR reduce la inflamación en pacientes con angioedema hereditario
4-Nov-2022 8:00 AM EDT
El tratamiento CRISPR reduce la inflamación en pacientes con angioedema hereditario
American College of Allergy, Asthma and Immunology (ACAAI)

Un nuevo estudio que se presenta en la Reunión Científica Anual del ACAAI de este año muestra que un tratamiento que usa una tecnología de edición genética de repeticiones palindrómicas cortas, agrupadas y regularmente interespaciadas logró aliviar la inflamación y reducir la frecuencia de los ataques.

Released: 8-Nov-2022 5:00 PM EST
MD Anderson Research Highlights: SITC 2022 Special Edition
University of Texas MD Anderson Cancer Center

This special edition features upcoming presentations by MD Anderson researchers at the Society for Immunotherapy of Cancer (SITC) 37th Annual Meeting, including immunotherapy advances in human papillomavirus (HPV)-positive head and neck cancers, microbiome signatures linked with specialized immune-cell clusters, and promising early activity from novel immunotherapy drugs in advanced melanoma and colorectal cancer.

Released: 8-Nov-2022 12:55 PM EST
Higher-Dose Pneumococcal Vaccines Improve Immune Response in ANCA-associated Vasculitis Patients Receiving Rituximab
American College of Rheumatology (ACR)

New research presented this week at ACR Convergence 2022, the American College of Rheumatology’s annual meeting, showed that a higher dose of pneumococcal vaccine safely and effectively improved antibody response in patients receiving rituximab for ANCA-associated vasculitis.

Released: 8-Nov-2022 12:50 PM EST
Study Finds Most Fetal Congenital Heart Block Screening Fails to Meet Guidelines
American College of Rheumatology (ACR)

New research presented this week at ACR Convergence, the American College of Rheumatology’s annual meeting, found that most echocardiography screening for fetal congenital heart block in anti-Ro- and anti-La-positive pregnancies did not follow recommended guidelines in one academic medical center.

Released: 8-Nov-2022 12:45 PM EST
Study Finds Spine Disease Is More Common in Chronic Recurrent Multifocal Osteomyelitis than Previously Thought
American College of Rheumatology (ACR)

New research presented this week at ACR Convergence 2022, the American College of Rheumatology’s annual meeting, shows that spine disease, once considered a rarity in chronic recurrent multifocal osteomyelitis, affects as many as 10-35% of patients and is asymptomatic in one-third.

Released: 8-Nov-2022 12:45 PM EST
Study Finds Holding Methotrexate for One Week after Flu Vaccine May Be as Effective as a Two-Week Hold
American College of Rheumatology (ACR)

New research presented this week at ACR Convergence, the American College of Rheumatology’s annual meeting, showed that discontinuing methotrexate for 1 week after seasonal influenza vaccination provided the same seroprotection as a 2 week discontinuation period in patients with RA.

Released: 8-Nov-2022 12:45 PM EST
Study Finds Combination Therapy Does Little to Slow Spine Damage in Radiographic Axial Spondyloarthritis Patients
American College of Rheumatology (ACR)

New research presented this week at ACR Convergence 2022, the American College of Rheumatology’s annual meeting, showed that combining a nonsteroidal anti-inflammatory drug and TNF inhibitor did not significantly slow radiographic spinal progression in radiographic axial spondyloarthritis patients.

Released: 8-Nov-2022 12:40 PM EST
Study Finds No Increased Cancer Risk in Rheumatology Patients with History of Malignancy Taking DMARDS and TNF Inhibitors
American College of Rheumatology (ACR)

New research presented this week at ACR Convergence, the organization's annual meeting, found no significant difference in cancer risk in patients with rheumatic disease & a history of malignancy taking biologic or targeted synthetic DMARDs compared to those treated with TNF inhibitors.

Released: 8-Nov-2022 12:30 PM EST
Study Finds Opioids Double Risk of Venous Thromboembolism in Rheumatoid Arthritis Patients
American College of Rheumatology (ACR)

New research presented this week at ACR Convergence 2022, the American College of Rheumatology’s annual meeting, found that adult RA patients starting opioids had twice the risk of venous thromboembolism (VTE) compared to patients starting nonsteroidal anti-inflammatory drugs (NSAIDs).

Released: 8-Nov-2022 12:20 PM EST
Study Links Lower Hydroxychloroquine Dose to More Hospitalizations for Systemic Lupus Erythematosus Flares
American College of Rheumatology (ACR)

New research presented this week at ACR Convergence 2022, the American College of Rheumatology’s annual scientific meeting, found that the recommended weight-based or non-weight-based dose of hydroxychloroquine led to more hospitalizations for flares among patients with systemic lupus erythematosus

Released: 8-Nov-2022 12:15 PM EST
Primary Care Provider Training Program Improves RA Care on Navajo Nation
American College of Rheumatology (ACR)

Research presented this week at ACR Convergence 2022, the American College of Rheumatology’s annual meeting, described a novel program that offers rheumatoid arthritis (RA) training to primary care providers in the Navajo Nation, the largest American Indian reservation in the United States.

Released: 8-Nov-2022 12:05 PM EST
Study Finds Early TNF Inhibitor Treatment Is Associated with Higher Heart Disease Risk in Ankylosing Spondylitis Patients — with Caveats
American College of Rheumatology (ACR)

New research presented this week at ACR Convergence 2022, the American College of Rheumatology’s annual meeting, found that early initiation of tumor necrosis factor (TNF) inhibitors was associated with higher risk of heart disease in patients diagnosed with ankylosing spondylitis.

Released: 8-Nov-2022 11:55 AM EST
Study Finds More Polyarticular JIA Patients Achieve Clinical Remission with Combined Conventional and Biologic DMARDs
American College of Rheumatology (ACR)

New research presented this week at ACR Convergence, the American College of Rheumatology’s annual meeting, demonstrated that polyarticular JIA patients were more likely to achieve clinical remission with a combination of conventional and biologic DMARDs compared with other treatment plans.

Released: 8-Nov-2022 11:55 AM EST
Study Finds NSAID Use and Age May Delay Conception in Spondyloarthritis Patients
American College of Rheumatology (ACR)

New research presented this week at ACR Convergence 2022, the American College of Rheumatology’s annual meeting, showed that treatment with nonsteroidal anti-inflammatory drugs (NSAIDs) and older age were associated with longer time to conception in spondyloarthritis patients.

Released: 8-Nov-2022 11:55 AM EST
New Analysis Finds Belimumab Improves Cutaneous Lupus Erythematosus in Patients with or without SLE
American College of Rheumatology (ACR)

New research presented this week at ACR Convergence 2022, the American College of Rheumatology’s annual meeting, found that the B-cell inhibitor belimumab significantly improved cutaneous lupus erythematosus (CLE) whether or not patients also had systemic lupus erythematosus (SLE or lupus).

Released: 8-Nov-2022 11:50 AM EST
Study Finds Lower Risk of Severe Infection and Hospitalization with Belimumab Compared to Oral Immunosuppressants
American College of Rheumatology (ACR)

New research presented this week at ACR Convergence 2022, the American College of Rheumatology’s annual meeting, found that the biologic B-cell inhibitor belimumab was associated with a lower risk of severe infections and hospitalizations compared to nonbiologic immunosuppressants.

Released: 8-Nov-2022 11:35 AM EST
Artificial Intelligence Shows Potential for Accurate Assessment of Nailfold Changes in Systemic Sclerosis Patients
American College of Rheumatology (ACR)

New research presented this week at ACR Convergence 2022, the American College of Rheumatology’s annual meeting, showed that the Vision Transformer, an open-source computer vision algorithm, could detect changes in nailfold capillaroscopy images from systemic sclerosis patients.

Released: 8-Nov-2022 11:30 AM EST
Researchers Develop a Risk Score to Help Detect ILD in Systemic Sclerosis Patients
American College of Rheumatology (ACR)

New research presented this week at ACR Convergence 2022, the American College of Rheumatology’s annual meeting, described a first-of-its-kind validated tool to screen for systemic sclerosis-associated interstitial lung disease.

Released: 8-Nov-2022 11:20 AM EST
Holding Mycophenolate Mofetil for 10 Days or More May Improve COVID-19 Vaccine Response
American College of Rheumatology (ACR)

New research presented this week at ACR Convergence 2022, the American College of Rheumatology’s annual meeting, demonstrated that withholding mycophenolate mofetil for 10 days significantly increased antibody response after 2 doses of COVID-19 vaccine, without a significant increase in flares.

Released: 8-Nov-2022 11:10 AM EST
Preterm Birth More Common in Unvaccinated Pregnant Patients with Rheumatic Disease and COVID-19
American College of Rheumatology (ACR)

New research presented this week at ACR Convergence 2022, the American College of Rheumatology’s annual meeting, found a greater number of preterm births in unvaccinated versus fully vaccinated pregnant patients with rheumatic disease and COVID-19.

Released: 8-Nov-2022 11:05 AM EST
Study Finds Gastrointestinal Symptoms in Systemic Scleroderma Unrelated to Disease-Specific Medications
American College of Rheumatology (ACR)

New research presented this week at ACR Convergence 2022, the American College of Rheumatology’s annual meeting, found no clear association between immunosuppressive or anti-fibrotic medications and worsening gastrointestinal symptoms in early systemic scleroderma.

Released: 8-Nov-2022 11:05 AM EST
Study Finds AAV Characteristics and Treatments Vary Across Lifespan
American College of Rheumatology (ACR)

New research presented this week at ACR Convergence 2022, the American College of Rheumatology’s annual meeting, demonstrated an association between age of diagnosis and clinical characteristics and treatments in Anti-neutrophil cytoplasmic antibody-associated vasculitis patients.

Released: 8-Nov-2022 10:05 AM EST
Study Finds Half of Patients with Low-Grade Proteinuria Develop Treatable Lupus Nephritis within Two Years
American College of Rheumatology (ACR)

New research presented this week at ACR Convergence 2022, the American College of Rheumatology’s annual meeting, found that 50% of people with low-grade proteinuria, which is protein in your urine, progress to clinical proteinuria within two years and show treatable lupus nephritis on biopsies.

Released: 8-Nov-2022 8:25 AM EST
Addressing Health Inequities Could Help Avert a Neurologic Health Crisis
American Neurological Association (ANA)

The closing plenary session at ANA2022 spotlighted neurologic health inequities and presented new research finding that neighborhood disadvantage strongly predicted likelihood of death from neurologic conditions independent of individual wealth and demographics.

   
Released: 7-Nov-2022 6:05 PM EST
Restored blood flow meant less pain, better quality of life for those with leg artery disease
American Heart Association (AHA)

estoring blood flow to the legs, whether through bypass surgery or a less invasive artery-opening procedure with a stent, reduced pain and improved quality of life for people with peripheral artery disease (PAD), according to preliminary, late-breaking research presented today at the American Heart Association’s Scientific Sessions 2022.

Newswise: Media Advisory: Cedars-Sinai Experts to Discuss Latest Brain Research
Released: 7-Nov-2022 1:35 PM EST
Media Advisory: Cedars-Sinai Experts to Discuss Latest Brain Research
Cedars-Sinai

Neuroscientists from Cedars-Sinai will present—and are available to comment on—cutting-edge brain research at the sixth International Human Single Neuron Meeting Nov. 10-11 at UCLA, and Neuroscience 2022, the annual meeting of the Society for Neuroscience, Nov. 12-16 in San Diego.

Newswise: Cedars-Sinai Leaders Share Expertise in Patient Experience at World Hospital Congress
Released: 7-Nov-2022 12:15 PM EST
Cedars-Sinai Leaders Share Expertise in Patient Experience at World Hospital Congress
Cedars-Sinai

Heitham T. Hassoun, MD, Vice President & Medical Director, Cedars Sinai International, is headlining a panel discussion about how healthcare professionals can improve the patient experience during the The International Hospital Federation’s upcoming World Hospital Congress.

Released: 6-Nov-2022 6:30 PM EST
Chest Pain Patients Benefit from Precision Diagnostic Testing Approach
Duke Health

A study comparing two approaches for diagnosing heart disease found that a risk analysis strategy is superior to the usual approach of immediately performing functional tests or catheterization for low- to intermediate-risk patients with new-onset chest pain.

Released: 6-Nov-2022 9:15 AM EST
Largest Randomized Trial Evaluates Steroids for Infant Heart Surgery
Duke Health

For more than four decades, doctors have been split on whether giving steroids during a pediatric open-heart surgery could be helpful for post-operative recovery. A new study is providing a bit more clarity, suggesting there are some benefits for certain kinds of patients.

31-Oct-2022 10:05 AM EDT
The COVID-19 pandemic has had direct and indirect impacts on the mortality of patients on dialysis
American Society of Nephrology (ASN)

During the COVID-19 pandemic in 2020, mortality risk for both COVID-19–positive and other patients on hemodialysis fluctuated in line with two waves of the pandemic in the general population.

31-Oct-2022 10:05 AM EDT
Conservative management vs. dialysis for preventing hospitalizations in patients with advanced kidney diseases and different ethnicities
American Society of Nephrology (ASN)

Researchers have compared the impact of conservative management vs. dialysis on hospitalization outcomes in patients with advanced kidney disease across different races/ethnicities.

31-Oct-2022 10:05 AM EDT
Strategy Suggests Combining Surrogate Markers for Kidney Disease Progression in Clinical Trials
American Society of Nephrology (ASN)

In clinical trials of patients with chronic kidney disease, combining information from the treatment effects on two markers of kidney disease progression—urinary albumin:creatinine ratio change and glomerular filtration rate slope—improves predictions of treatment effects on clinical endpoints.

31-Oct-2022 10:05 AM EDT
Did having kidney disease and other conditions affect COVID-19 outcomes in different waves of the pandemic?
American Society of Nephrology (ASN)

During 4 waves of the COVID-19 pandemic in New York City, the risk of severe COVID-19 was associated with pre-existing chronic kidney disease, as well as heart disease, diabetes, and hypertension.

Released: 5-Nov-2022 10:30 AM EDT
Comparative Study of Two Heart Failure Drugs Finds No Difference in Outcomes
Duke Health

In a head-to-head comparison of two so-called ‘water pills’ that keep fluid from building up in patients with heart failure, the therapies proved nearly identical in reducing deaths, according to a large study led by Duke Health researchers.

31-Oct-2022 10:05 AM EDT
Risks of kidney failure and death differ in Black and white veterans over time after chronic kidney disease onset
American Society of Nephrology (ASN)

Among US veterans with chronic kidney disease (CKD), Black individuals had a higher risk of developing kidney failure compared with White veterans, and their risk was more pronounced in the early years after kidney disease onset.

31-Oct-2022 10:05 AM EDT
Long-Term Exposure to Air Pollution May Increase Kidney Disease Risk
American Society of Nephrology (ASN)

Among adults with normal kidney function, exposure to higher concentrations of components of air pollution was linked with higher risks of later developing chronic kidney disease.

2-Nov-2022 9:45 AM EDT
High-Impact Clinical Trials Yield Results that Could Improve Kidney Care
American Society of Nephrology (ASN)

The results of numerous high-impact clinical trials that could affect kidney-related medical care will be presented in-person and online at ASN Kidney Week 2022 November 3–November 6.



close
2.96565